Promoting Effect of Basic Fibroblast Growth Factor in Synovial Mesenchymal Stem Cell-Based Cartilage Regeneration

Synovial mesenchymal stem cell (SMSC) is the promising cell source of cartilage regeneration but has several issues to overcome such as limited cell proliferation and heterogeneity of cartilage regeneration ability. Previous reports demonstrated that basic fibroblast growth factor (bFGF) can promote proliferation and cartilage differentiation potential of MSCs in vitro, although no reports show its beneficial effect in vivo. The purpose of this study is to investigate the promoting effect of bFGF on cartilage regeneration using human SMSC in vivo. SMSCs were cultured with or without bFGF in a growth medium, and 2 × 105 cells were aggregated to form a synovial pellet. Synovial pellets were implanted into osteochondral defects induced in the femoral trochlea of severe combined immunodeficient mice, and histological evaluation was performed after eight weeks. The presence of implanted SMSCs was confirmed by the observation of human vimentin immunostaining-positive cells. Interestingly, broad lacunae structures and cartilage substrate stained by Safranin-O were observed only in the bFGF (+) group. The bFGF (+) group had significantly higher O’Driscoll scores in the cartilage repair than the bFGF (−) group. The addition of bFGF to SMSC growth culture may be a useful treatment option to promote cartilage regeneration in vivo.

[1]  P. Pavasant,et al.  Basic fibroblast growth factor regulates phosphate/pyrophosphate regulatory genes in stem cells isolated from human exfoliated deciduous teeth , 2018, Stem Cell Research & Therapy.

[2]  N. Tsumaki,et al.  Considerations in hiPSC-derived cartilage for articular cartilage repair , 2018, Inflammation and regeneration.

[3]  D. Hart,et al.  First-in-Human Pilot Study of Implantation of a Scaffold-Free Tissue-Engineered Construct Generated From Autologous Synovial Mesenchymal Stem Cells for Repair of Knee Chondral Lesions , 2018, The American journal of sports medicine.

[4]  H. Yoshikawa,et al.  Impact of dexamethasone concentration on cartilage tissue formation from human synovial derived stem cells in vitro , 2018, Cytotechnology.

[5]  S. Werner,et al.  Fibroblast growth factors: key players in regeneration and tissue repair , 2017, Development.

[6]  S. Werner,et al.  Fibroblast growth factors: key players in regeneration and tissue repair , 2017 .

[7]  D. Hart,et al.  Characterization of Mesenchymal Stem Cell-Like Cells Derived From Human iPSCs via Neural Crest Development and Their Application for Osteochondral Repair , 2017, Stem cells international.

[8]  H. Yoshikawa,et al.  Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation , 2017, Osteoporosis International.

[9]  A. Mobasheri,et al.  Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair , 2016, Front. Genet..

[10]  D. Hart,et al.  Synovial mesenchymal stem cells from osteo- or rheumatoid arthritis joints exhibit good potential for cartilage repair using a scaffold-free tissue engineering approach. , 2016, Osteoarthritis and cartilage.

[11]  K. Matsumoto,et al.  Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats. , 2016, Osteoarthritis and cartilage.

[12]  M. Katoh FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review) , 2016, International journal of molecular medicine.

[13]  G. Eckert,et al.  Role of Sox9 in Growth Factor Regulation of Articular Chondrocytes , 2015, Journal of cellular biochemistry.

[14]  P. Brama,et al.  Long-Term Expansion, Enhanced Chondrogenic Potential, and Suppression of Endochondral Ossification of Adult Human MSCs via WNT Signaling Modulation , 2015, Stem cell reports.

[15]  Manuel A. González,et al.  Cell Senescence Abrogates the Therapeutic Potential of Human Mesenchymal Stem Cells in the Lethal Endotoxemia Model , 2014, Stem cells.

[16]  H. Shim,et al.  Intra‐Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof‐of‐Concept Clinical Trial , 2014, Stem cells.

[17]  Daniel A Grande,et al.  Articular Cartilage Repair , 2013, Cartilage.

[18]  Milan Držík,et al.  A cell-free nanofiber composite scaffold regenerated osteochondral defects in miniature pigs. , 2013, International journal of pharmaceutics.

[19]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[20]  N. Weber,et al.  Fibroblast growth factor 2 enhances the kinetics of mesenchymal stem cell chondrogenesis. , 2012, Biochemical and biophysical research communications.

[21]  C. T. Buckley,et al.  Expansion in the presence of FGF-2 enhances the functional development of cartilaginous tissues engineered using infrapatellar fat pad derived MSCs. , 2012, Journal of the mechanical behavior of biomedical materials.

[22]  I. Sekiya,et al.  Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs , 2012, Cytotherapy.

[23]  J. Kim,et al.  Enhanced proliferation and chondrogenic differentiation of human synovium-derived stem cells expanded with basic fibroblast growth factor. , 2011, Tissue engineering. Part A.

[24]  D. Hart,et al.  The influence of skeletal maturity on allogenic synovial mesenchymal stem cell-based repair of cartilage in a large animal model. , 2010, Biomaterials.

[25]  J. Kim,et al.  Effect of serum and growth factors on chondrogenic differentiation of synovium-derived stromal cells. , 2009, Tissue engineering. Part A.

[26]  A. Choo,et al.  Differentiation and enrichment of expandable chondrogenic cells from human embryonic stem cells in vitro , 2009, Journal of cellular and molecular medicine.

[27]  I. Sekiya,et al.  Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  I. Sekiya,et al.  Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit , 2008, Cell and Tissue Research.

[29]  Hiromichi Fujie,et al.  Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. , 2007, Biomaterials.

[30]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[31]  Y. Seyama,et al.  FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. , 2007, Biochemical and biophysical research communications.

[32]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[33]  J. Barker,et al.  Self-Renewing and Differentiating Properties of Cortical Neural Stem Cells Are Selectively Regulated by Basic Fibroblast Growth Factor (FGF) Signaling via Specific FGF Receptors , 2007, The Journal of Neuroscience.

[34]  M. Neil,et al.  Structurally Distinct Membrane Nanotubes between Human Macrophages Support Long-Distance Vesicular Traffic or Surfing of Bacteria1 , 2006, The Journal of Immunology.

[35]  Y. Sakaguchi,et al.  Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. , 2005, Arthritis and rheumatism.

[36]  D. Zurakowski,et al.  Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  V. Goldberg,et al.  FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells , 2005, Journal of cellular physiology.

[38]  N. Itoh,et al.  Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.

[39]  S. Fujita,et al.  The expression of fibroblast growth factor receptor-3 in synovial osteochondromatosis of the temporomandibular joint. , 2004, Archives of oral biology.

[40]  Shigeyuki Wakitani,et al.  Autologous Bone Marrow Stromal Cell Transplantation for Repair of Full-Thickness Articular Cartilage Defects in Human Patellae: Two Case Reports , 2004, Cell transplantation.

[41]  I. Mason Fibroblast growth factors , 2003, Current Biology.

[42]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Y. Kato,et al.  Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. , 2001, Biochemical and biophysical research communications.

[44]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[45]  Nobuyuki Itoh,et al.  Fibroblast growth factors , 2001, Genome Biology.

[46]  S. Murakami,et al.  Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[48]  S W O'Driscoll,et al.  Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. , 1988, The Journal of bone and joint surgery. American volume.

[49]  H. Yoshikawa,et al.  Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice. , 2018, Bone.

[50]  Hideki Yoshikawa,et al.  Preparation of Scaffold-Free Tissue-Engineered Constructs Derived from Human Synovial Mesenchymal Stem Cells Under Low Oxygen Tension Enhances Their Chondrogenic Differentiation Capacity. , 2016, Tissue engineering. Part A.

[51]  D. Hart,et al.  Osteochondral repair using a scaffold-free tissue-engineered construct derived from synovial mesenchymal stem cells and a hydroxyapatite-based artificial bone. , 2014, Tissue engineering. Part A.

[52]  S. Seong,et al.  Chondrogenic potentials of human synovium-derived cells sorted by specific surface markers. , 2013, Osteoarthritis and cartilage.

[53]  S. Ichinose,et al.  In vitro chondrogenesis of human synovium‐derived mesenchymal stem cells: Optimal condition and comparison with bone marrow‐derived cells , 2006, Journal of cellular biochemistry.

[54]  M. Goldring,et al.  The control of chondrogenesis , 2006, Journal of cellular biochemistry.

[55]  A. Hampl,et al.  Basic fibroblast growth factor and its receptors in human embryonic stem cells. , 2005, Folia histochemica et cytobiologica.

[56]  W. Rombouts,et al.  Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture , 2003, Leukemia.